ADMA - Adma Biologics Inc
IEX Last Trade
17.29
0.070 0.405%
Share volume: 3,190,878
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$17.22
0.07
0.41%
Summary score
16%
Profitability
8%
Dept financing
17%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
144.61%
Return on assets
-13.4%
Return on sales
-226.4%
Return on invested capital
-27.08%
Total debt ratio
80.49%
Debt ratio change over timeo
-1.76%
Current Ratio
5.92%
Quick Ratio
4.04%
Cash Position Ratio
3.12%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-29.55%
Return on assets
-7.41%
Return on sales
-143.66%
Return on invested capital
-50.59%
Total debt ratio
66.82%
Debt ratio change over timeo
-2.44%
Current Ratio
8.89%
Quick Ratio
5.25%
Cash Position Ratio
4.56%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-26.25%
Return on assets
-8.94%
Return on sales
-219.89%
Return on invested capital
-56.57%
Total debt ratio
59.86%
Debt ratio change over time
-1.97%
Current Ratio
11.1%
Quick Ratio
6.75%
Cash Position Ratio
5.88%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
93.91%
Return on assets
-87.1%
Return on sales
247.09%
Return on invested capital
-9.11%
Total debt ratio
-176.17%
Debt ratio change over time
-1.76%
Current Ratio
-12.12%
Quick Ratio
-8.5%
Cash Position Ratio
-7.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ADMA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 144.61% | -3.05% | 11.55% | 6.27% |
| Return on assets | -13.4% | 3.6% | 3.57% | 5.27% |
| Return on sales | -226.4% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -27.08% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 46% | 59% | 71% |
| Total debt ratio | 80.49% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.76% | 6.09% | 6.03% | 1.53% |
| Dept financing | 20% | 50% | 43% | 14% |
| Current Ratio | 8.89% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 5.25% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.56% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 21% | 40% | 44% |
| Short-term ratios | ADMA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -29.55% | -25.62% | 17.94% | 7.14% |
| Return on assets | -7.41% | 3.26% | 3.67% | 4.71% |
| Return on sales | -143.66% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -50.59% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 66.82% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -2.44% | -23.44% | 9.66% | 0.6% |
| Dept financing | 16% | 25% | 45% | 8% |
| Current Ratio | 8.89% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 5.25% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.56% | 1.48% | 0.76% | 1.49% |
| Liquididy | 75% | 23% | 18% | 32% |